These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Respiratory syncytial virus (RSV) as a common cause of respiratory illness in children younger than 5 years. Poehling KA; Hickson GB Ambul Pediatr; 2003; 3(6):342-4. PubMed ID: 14616052 [No Abstract] [Full Text] [Related]
5. Antibodies for prevention and treatment of respiratory syncytial virus infections in children. Geevarghese B; Simões EA Antivir Ther; 2012; 17(1 Pt B):201-11. PubMed ID: 22311607 [TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection. Robinson RF; Nahata MC Am J Health Syst Pharm; 2000 Feb; 57(3):259-64. PubMed ID: 10674778 [TBL] [Abstract][Full Text] [Related]
7. Prevention of Respiratory Syncytial Virus Infection: From Vaccine to Antibody. Huang K; Wu H Microbiol Spectr; 2014 Aug; 2(4):AID-0014-2014. PubMed ID: 26104207 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model. Ottolini MG; Porter DD; Hemming VG; Zimmerman MN; Schwab NM; Prince GA Bone Marrow Transplant; 1999 Jul; 24(1):41-5. PubMed ID: 10435733 [TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus: babies and antibodies. Hemming VG; Prince GA Infect Agents Dis; 1992 Feb; 1(1):24-32. PubMed ID: 1365525 [No Abstract] [Full Text] [Related]
11. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627 [TBL] [Abstract][Full Text] [Related]
12. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Meissner HC; Long SS; Pediatrics; 2003 Dec; 112(6 Pt 1):1447-52. PubMed ID: 14654628 [TBL] [Abstract][Full Text] [Related]
13. Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection. Mejias A; Garcia-Maurino C; Rodriguez-Fernandez R; Peeples ME; Ramilo O Vaccine; 2017 Jan; 35(3):496-502. PubMed ID: 27692523 [TBL] [Abstract][Full Text] [Related]
15. Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection. Haynes LM; Tonkin J; Anderson LJ; Tripp RA J Virol; 2002 Jul; 76(14):6873-81. PubMed ID: 12072488 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats. Wyde PR; Moore DK; Hepburn T; Silverman CL; Porter TG; Gross M; Taylor G; Demuth SG; Dillon SB Pediatr Res; 1995 Oct; 38(4):543-50. PubMed ID: 8559607 [TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus: different criteria for palivizumab use in different areas? Mitchell I South Med J; 2007 Jul; 100(7):661-2. PubMed ID: 17639741 [No Abstract] [Full Text] [Related]
18. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group. Groothuis JR; Simoes EA; Hemming VG Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741 [TBL] [Abstract][Full Text] [Related]
19. New strategies for control of respiratory syncytial virus infection. Nokes JD; Cane PA Curr Opin Infect Dis; 2008 Dec; 21(6):639-43. PubMed ID: 18978532 [TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus therapy and prophylaxis: have we finally turned the corner? Hegele RG Eur Respir J; 2011 Aug; 38(2):246-7. PubMed ID: 21804160 [No Abstract] [Full Text] [Related] [Next] [New Search]